News • December 2, 2024
A newly published NEJM article by BIDMC pathologist Richard Haspel, MD, and hematologist Brian Carney, MD, calls out the discriminatory practices of the NCAA and U.S. military in requiring individuals to be tested for sickle cell trait. Click to learn more.
News • November 18, 2024
Beth Israel Deaconess Medical Center (BIDMC) is one of the award recipients for the Advanced Research Projects Agency for Health (ARPA-H) Sprint for Women’s Health. The recipients were selected from more than 1,700 submissions in the U.S. and 34 countries. BIDMC will assess brain disorders in women through a new, non-invasive MRI imaging biomarker as part of the research of HMFP member David Alsop, PhD, professor of radiology and director of MRI research. Conditions such as Alzheimer’s disease, dementia, and multiple sclerosis (MS) disproportionately affect women, and this research could lead to advances in their detection and treatment. Learn more.
News • November 13, 2024
Physicians, researchers, and other leaders from Beth Israel Deaconess Medical Center will present their latest research and clinical advancements in cardiovascular care from November 16-18 at the American Heart Association Scientific Sessions. View the list.
News • November 11, 2024
With the launch of the chemistry analyzer, the clinical pathology team’s ability to process patient samples, especially cancer patient samples, and perform hundreds of assays at-scale was about to leap 20 years ahead, almost overnight. The launch is a major step forward to build world-class personalized precision diagnostics for our cancer patients.
News • November 4, 2024
Pathologist explains the latest report from the American Cancer Society that found an increasing incidence for breast cancer in young women.
This rapid, on-site testing is essential for the diagnosing and monitoring of acute leukemia, lymphoma, plasma cell myeloma and other hematologic disorders.
